Training activity information
Details
Review pharmacological treatments for patients presenting with the following and discuss with supervisor:
- Chest pain/coronary disease
- Heart failure
- Hypertension
- Atrial fibrillation
Type
Developmental training activity (DTA)
Evidence requirements
Evidence the activity has been undertaken by the trainee.
Reflection on the activity at one or more time points after the event including learning from the activity and/or areas of the trainees practice for development.
An action plan to implement learning and/or to address skills or knowledge gaps identified.
Reflective practice guidance
The guidance below is provided to support reflection at different time points, providing you with questions to aid you to reflect for this training activity. They are provided for guidance and should not be considered as a mandatory checklist. Trainees should not be expected to provide answers to each of the guidance questions listed.
Before action
- What is the intended outcome of being able to review pharmacological treatments for common cardiac conditions and discuss them with your supervisor? What is the importance of understanding different drug classes and their mechanisms of action?
- What are the main pharmacological treatments used for chest pain/coronary disease, heart failure, hypertension, and atrial fibrillation? What are their mechanisms of action, indications, contraindications, and potential side effects? What are the current guidelines for pharmacological management of these conditions?
- What do you anticipate learning about the principles of cardiac pharmacology and how to integrate pharmacological treatments into the overall management of cardiac patients? How will you develop your knowledge of different drug therapies?
- How will you prepare by reviewing relevant clinical guidelines? Will you identify specific patient cases to discuss with your supervisor to understand the rationale behind different treatment choices?
In action
- For each condition, what are the key pharmacological agents you are considering and what are their mechanisms of action and expected benefits?
- How are you taking into account individual patient factors (e.g., comorbidities, other medications) when reviewing treatment options?
- What are the potential side effects and contraindications of the medications you are reviewing?
- How are you structuring your review and preparing to discuss your findings with your supervisor? What specific questions do you plan to ask?
- Are you considering alternative treatment algorithms or guidelines?
- Are there any specific cases or scenarios that are prompting your review of these treatments?
On action
- What were the key pharmacological agents and treatment strategies you reviewed for each of these conditions? What factors did you consider when evaluating their appropriateness?
- What did you learn about the current pharmacological management of these common cardiac conditions? Were there any areas where guidelines or evidence seemed complex or conflicting? How did your review process prepare you for discussion with your supervisor?
- What will you take from this experience to further develop your knowledge of cardiac pharmacology? What specific drug classes or treatment algorithms require further study? What questions do you plan to discuss with your supervisor to deepen your understanding?
Beyond action
- Have you reflected on the pharmacological treatments you initially reviewed for these conditions? How has your understanding of the mechanisms of action, indications, contraindications, and potential side effects of these medications evolved?
- How have discussions with your supervisor and exposure to real-world clinical scenarios enhanced your knowledge of how these medications are used in practice and tailored to individual patient needs?
- What resources (e.g., national guidelines, drug formularies) do you now routinely consult to ensure you have the most up-to-date information on pharmacological treatments?
- Reflecting on any areas where your understanding of pharmacological treatments was initially limited, how have you addressed these gaps in your knowledge?
- How will your growing understanding of cardiac pharmacology inform your interpretation of diagnostic tests and contribute to holistic patient management?
Relevant learning outcomes
| # | Outcome |
|---|---|
| # 7 |
Outcome
Critically appraise the role of cardiac diagnostic procedures within a range of patient presentations and pathways. |
| # 8 |
Outcome
Demonstrate the ability to communicate effectively with patients, carers and the wider multidisciplinary team. |